SHANA FEARNLEY: Open Payments
NPI 1861480642 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$242 in 9 payments from 6 companies in 2025. Trend: 2023 $214 · 2024 $177 · 2025 $242
Food & beverage: $242
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $60 |
| SK Life Science, Inc. | 2 | $56 |
| Biogen, Inc. | 2 | $52 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $20 |
Products named: INGREZZA, SKYCLARYS, JOURNAVX, HYQVIA, LEQEMBI, Ocrevus Zunovo.
Industry payments across NV — which companies pay providers there.
